Connexin 26 and 30 mutations in paediatric patients with congenital, non-syndromic hearing loss treated with cochlear implantation in Mediterranean Turkey

J Laryngol Otol. 2013 Jan;127(1):33-7. doi: 10.1017/S0022215112002587. Epub 2012 Nov 22.

Abstract

Objective: Mutations in the genes for connexin 26 (GJB2) and connexin 30 (GJB6) play an important role in autosomal recessive, non-syndromic hearing loss. This study aimed to detect the 35delG and 167delT mutations of the GJB2 gene and the del(GJB6-D13S1830) mutation of the GJB6 gene in paediatric patients diagnosed with congenital, non-syndromic hearing loss and treated with cochlear implantation in Mediterranean Turkey.

Materials and method: We included 94 children diagnosed with congenital, non-syndromic hearing loss and treated with cochlear implantation. Blood samples were collected, DNA extracted and an enzyme-linked immunosorbent assay performed to enable molecular diagnosis of mutations.

Results: Of the 94 children analysed, the 35delG mutation was detected in 12 (12.7 per cent): 10 (83.3 per cent) were homozygous and 2 (16.7 per cent) heterozygous mutant. The 167delT and del(GJB6-D13S1830) mutations were not detected.

Conclusion: The GJB2-35delG mutation is a major cause of congenital, non-syndromic hearing loss in this study population.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Cochlear Implantation*
  • Connexin 26
  • Connexin 30
  • Connexins / genetics*
  • Connexins / metabolism
  • DNA / genetics*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gene Frequency
  • Genotype
  • Hearing Loss / congenital
  • Hearing Loss / genetics*
  • Hearing Loss / surgery
  • Humans
  • Infant
  • Male
  • Mutation*
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Turkey

Substances

  • Connexin 30
  • Connexins
  • GJB2 protein, human
  • GJB6 protein, human
  • Connexin 26
  • DNA